Dr. Safder Ganaie is a Senior Research Associate at the Department of Pathology and Immunology, Washington University, USA. He obtained his master’s degree in Biotechnology from the University of Kashmir, India. In 2012, he joined The University of Kansas Medical Center for his doctoral studies and earned his PhD degree with honors in 2018. Dr. Ganaie worked on Parvovirus B19 and Bunyaviruses during his doctoral studies. He made some important discoveries about how parvovirus B19 replicates in erythroid progenitor cells and revealed the role of RNA-binding proteins in Parvovirus RNA splicing. His studies on Hantavirus also revealed the mechanism of preferential translational of hantaviral mRNAs through Nucleocapsid-vRNA interaction with ribosomes and also identified small molecule inhibitors that target the interaction to limit Hantavirus infection of cells. For his outstanding doctoral research accomplishments, Safder received the 2018-Micro Remi Amelunxen Award from the University of Kansas. He then joined Washington University for his postdoctoral studies and started exploring the host-pathogen interaction. He continued his research on bunyaviruses and made a breakthrough discovery in the field by identifying LRP1 as a proteinaceous cellular receptor for Rift Valley Fever Virus in a genome-wide CRISPR Cas9 screen. Dr. Ganaie is currently working on bunyaviruses like Oropouche, LaCrosse, and SFTSV and exploring the viral entry pathways.